Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

17.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
17.1K
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

4
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
4
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

990
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
990
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

226
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
226
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

1
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
1
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

1.9K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Yellow Dialyzer: A Rare Manifestation of Profound Hyperbilirubinemia.

The Israel Medical Association journal : IMAJ·2026
Same author

Contrast Media in Hospitalized Patients with Acute Kidney Injury: Renal and Clinical Outcomes.

American journal of nephrology·2026
Same author

Brown tumor of the patella in a long-term hemodialysis patient.

Kidney international·2026
Same author

Fungal peritonitis in peritoneal dialysis patients: a nationwide cohort study.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2025
Same author

A Novel CLCN1 Gene Mutation Associated with Hypokalemic Periodic Paralysis in a Pregnant Woman.

The Israel Medical Association journal : IMAJ·2024
Same author

Post-contrast acute kidney injury in the super-elder patients: a CT-scan perspective.

Japanese journal of radiology·2024

Related Experiment Video

Updated: Apr 17, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.9K

[Giant cell arteritis--old questions, current answers].

Alon Bnaya, Gideon Nesher, Moshe Sonenblick

    Harefuah
    |February 7, 2015
    PubMed
    Summary

    Giant cell arteritis (GCA) is a common vasculitis in the elderly. Diagnosis relies on clinical signs, inflammatory markers, and temporal artery biopsy, with ultrasound aiding detection. Glucocorticoids and aspirin are key treatments.

    Area of Science:

    • Rheumatology
    • Vasculitis
    • Internal Medicine

    Context:

    • Giant cell arteritis (GCA) is the most prevalent systemic vasculitis affecting the elderly population.
    • While its incidence has increased over decades, recent trends show stabilization in certain regions.
    • GCA presents with diverse symptoms, including cranial arteritis, systemic effects, and polymyalgia rheumatica (PMR).

    Purpose:

    • To summarize the current understanding of Giant Cell Arteritis (GCA) diagnosis and management.
    • To highlight diagnostic criteria, including clinical presentation, inflammatory markers, and temporal artery biopsy.
    • To review imaging modalities and therapeutic strategies for GCA.

    Summary:

    • Diagnosis involves clinical assessment, elevated inflammatory markers, and a temporal artery biopsy (10-20 mm, potentially bilateral).

    More Related Videos

    Mouse Models for Graft Arteriosclerosis
    07:37

    Mouse Models for Graft Arteriosclerosis

    Published on: May 14, 2013

    14.3K
    Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro
    10:05

    Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro

    Published on: January 25, 2017

    16.1K

    Related Experiment Videos

    Last Updated: Apr 17, 2026

    An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
    06:35

    An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

    Published on: February 8, 2019

    7.9K
    Mouse Models for Graft Arteriosclerosis
    07:37

    Mouse Models for Graft Arteriosclerosis

    Published on: May 14, 2013

    14.3K
    Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro
    10:05

    Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro

    Published on: January 25, 2017

    16.1K
  • Color duplex ultrasound can identify the "dark halo sign" with high specificity, aiding in diagnosis and ruling out GCA in low-risk patients.
  • Treatment primarily involves glucocorticoids and anti-platelet agents like aspirin to reduce ischemic complications; effective steroid-sparing agents are lacking, though methotrexate may be considered for high-risk individuals.

    • Impact:

    • Improved diagnostic accuracy through understanding biopsy nuances and ultrasound findings.
    • Enhanced patient outcomes via optimized treatment strategies combining glucocorticoids and aspirin.
    • Informed clinical decision-making regarding GCA management and the limited options for steroid-sparing therapy.